-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Biomarin Pharmaceutical Inc quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
- Biomarin Pharmaceutical Inc Cost of Revenue for the quarter ending September 30, 2024 was $188M, a 47.2% increase year-over-year.
- Biomarin Pharmaceutical Inc Cost of Revenue for the twelve months ending September 30, 2024 was $565M, a 8.32% increase year-over-year.
- Biomarin Pharmaceutical Inc annual Cost of Revenue for 2023 was $515M, a 6.45% increase from 2022.
- Biomarin Pharmaceutical Inc annual Cost of Revenue for 2022 was $484M, a 2.8% increase from 2021.
- Biomarin Pharmaceutical Inc annual Cost of Revenue for 2021 was $471M, a 10.3% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)